Genetically modified organs

A new study in the Journal of Hepatology reports the first successful liver xenotransplant from a genetically engineered pig into a living human; a milestone that could reshape the future of organ transplantation. The 71-year-old patient, who was not eligible for a human liver transplant, received a graft from a modified pig engineered with 10 gene edits to improve compatibility. For more than a month, the pig liver carried out essential functions such as bile production and coagulation factor synthesis. Although the graft was removed on day 38 due to a complication known as xenotransplantation-associated thrombotic microangiopathy, the patient ultimately survived 171 days, demonstrating that a pig liver can operate inside a human body for an extended period.

                            

Researchers and global health experts view this case as an important early proof of concept at a time when thousands die each year waiting for donor organs. With organ shortages especially severe in countries like China, where liver failure cases far outnumber available transplants, this experimental success offers a glimpse of what future solutions may look like. Experts emphasize both the promise and the ongoing obstacles, but agree that the case marks a turning point. As editorialist Heiner Wedemeyer noted, genetically engineered pig organs may one day provide entirely new options for patients with liver failure, signaling the beginning of a new chapter in transplant medicine.

How Gene Editing Could Solve the Organ Shortage

 

Gene editing offers a revolutionary solution to the ongoing shortage of human organs for transplantation by creating genetically modified animals, whose organs could be more compatible with human recipients. This process involves altering the DNA of animals (mainly pigs) to reduce the risk of immune rejection when their organs are transplanted into humans. For instance, researchers are using CRISPR and other gene editing tools to disable certain genes in pigs that cause immune rejection and to insert human genes that help the body accept the organ as its own. These gene-edited animals could provide a continuous, renewable source of organs, potentially saving thousands of lives each year.

However, there are significant concerns. Ethical issues surrounding animal modification, the welfare of genetically altered animals, and the long-term safety of these organs in humans are major challenges. Additionally, there are risks of animal borne diseases where these might transfer from animals to humans demanding strict safety measures. Another issue is the potential for a few large biotech companies to dominate the market, possibly making these organs too expensive for many who need them. Despite these challenges, with careful research, regulation, and ethical oversight, gene edited animal organs could become a vital solution to the global organ transplant crisis.